ASK YOUR U.S. REPRESENTATIVE TO JOIN THE CONGRESSIONAL PATH CAUCUS.

About the Congressional PATH Caucus

The Congressional Psychedelics Advancing Therapies (PATH) Caucus is a bipartisan Congressional caucus co-chaired by Representatives Jack Bergman (R-MI) and Lou Correa (D-CA). Founded to address the urgent national mental health crisis, the PATH Caucus promotes rigorous, FDA-aligned clinical research into the therapeutic potential of psychedelic-assisted treatments for mental health disorders.

Apollo Pact's Role

Apollo Pact serves as the primary patient advocacy organization supporting the PATH Caucus. Our work alongside Caucus leadership includes:

Congressional Education & Briefings We organize and support Capitol Hill briefings that bring together leading researchers, clinicians, patients and other stakeholders to educate members of Congress and their staff on the latest science from FDA-regulated psychedelic clinical trials.

Patient Voices on the Hill We amplify the lived experiences of research participants and patients, ensuring that Congressional discussions about potential psychedelic therapies are grounded in real human outcomes — not just data.

  • Crenshaw's Psychedelic Research Provision Signed into Law

    “This legislation is a historic accomplishment for our Country, our servicemembers, and for science. This achievement, coupled with the recent actions of the VA, have shown psychedelic-assisted therapies are moving from theoretical ideas to tangible therapeutic treatments,” said former Congresswoman Mimi Walters, chair of the patient advocacy group, Apollo Pact. “This will give our active-duty service men and women more options to heal. I commend Reps. Crenshaw & Luttrell on their leadership to bring innovative solutions to the forefront.”